Test Price
2,800 AEDโ Home Collection Available
MYBPC3 Gene Cardiomyopathy, Familial Hypertrophic Type 4 Genetic Test in UAE | 2800 AED | DHA Certified
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM โ 11 PM).
Clinical Guidance: Telephonic Post-Test Genetic Counseling included with result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYBPC3 Gene Cardiomyopathy, Familial Hypertrophic Type 4 Genetic Test employs Next-Generation Sequencing (NGS) to identify pathogenic variants across the entire MYBPC3 gene, including deep intronic regions and copy number changes. This test is essential for confirming a diagnosis of familial hypertrophic cardiomyopathy (HCM), guiding family cascade screening, and enabling precision cardiac surveillance in accordance with international cardiology guidelines.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing Panel) |
|---|---|---|
| Precision / Sensitivity | 99.9% diagnostic sensitivity, detects deep intronic and copy-number variants | ~85โ90% for common exonic mutations; limited CNV resolution |
| Methodology | Full MYBPC3 gene sequencing via NGS with deletion/duplication analysis | Exon-by-exon Sanger sequencing; multi-step workflow |
| Turnaround Time | 3 to 4 Weeks | 6 to 10 Weeks (sequential analysis) |
Physician Insight & Safety Protocols
โGenetic results for MYBPC3 must always be integrated with echocardiographic findings and a detailed family history. A positive variant alone does not confirm phenotype severity nor dictate therapy. Post-test genetic counseling is essential for informed clinical decisions and family risk assessment.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Medication Advisory
Do Not Alter Prescribed Medications
Never discontinue or adjust cardiac medications based solely on a genetic test report. Any change in therapy must be supervised by a cardiologist or treating physician. Unsupervised modification can lead to serious clinical deterioration.
Exclusion Criteria & ER Red Flags
- Inappropriate sample collection (clotted blood, insufficient DNA yield).
- Received whole blood transfusion within the last 120 days (may interfere with germline DNA analysis).
- Lack of informed consent for minors, as mandated by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: Sudden chest pain, syncope (fainting), severe shortness of breath, or palpitations with dizziness โ proceed to the nearest ER immediately; this test is not for acute crisis diagnosis.
Patient FAQ & Clinical Guidance
1. What does the MYBPC3 genetic test detect?
A: This test identifies pathogenic variants in the MYBPC3 gene responsible for familial hypertrophic cardiomyopathy type 4. It enables precision cardiac management and targeted family cascade screening. The analysis covers the entire coding region, flanking intronic boundaries, and detects single nucleotide variants, small insertions/deletions, and larger copy number changes.
2. How long does it take to get results?
A: The turnaround time is 3 to 4 weeks from sample receipt. Results are delivered securely with a telephonic clinical interpretation. Expedited processing may be available upon request.
3. Is home blood collection available in Dubai and Abu Dhabi?
A: Yes, we offer VIP Mobile Phlebotomy with temperature-controlled cold-chain logistics across all UAE emirates from 8 AM to 11 PM. Our team complies with DHA and MOHAP standards, and same-day pickup is available for urgent requests.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Laboratory operations are conducted under DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | MYBPC3 Gene Cardiomyopathy, Familial Hypertrophic Type 4 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) โ EDTA tube |
| Methodology Used | Next Generation Sequencing (NGS) with deletion/duplication analysis |
| ICD-10-CM Code | I42.1 (Obstructive hypertrophic cardiomyopathy) |
| LOINC Code | 21636-6 (MYBPC3 gene mutation analysis) |
| DHA Facility License & Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians